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CHAPTER 1 
      INTRODUCTION  
An individual whose major is Rehabilitation Administration and Services (RAS) has a 
duty to ensure that individuals with disabilities or diseases are offered support through 
psychological, medical, and independent living services.   Additionally, these programs must 
deliver results and confirm their effectiveness for the individuals afflicted with a disease or 
disability.  In order to provide or establish the appropriate rehabilitation plan for an individual, 
one needs to acquaint themselves fully with diseases and disorders.  This paper explores 
Parkinson’s disease (PD) and reasons why it is important to the field of Rehabilitation 
Administration and Services.   
Based on the National Institute of Neurological Disorders and Stroke (NINDS), the 
United States alone has about 500,000 people that suffer from this disease and 50,000 new cases 
are recorded annually.  Furthermore, the statistics provide are expected to increase with the age 
of the population.  PD is a worldwide disease that affects those aged in their 70s and 80s.  
Stricken individuals that suffer from this disease have differing symptoms then other patients.  
Parkinson’s victims predominantly affect older individuals but in rare cases, it is seen in younger 
patients as well.  Young-onset Parkinson is the term used to describe those individuals between 
21 and 40 that have early signs of Parkinson (Rana, Siddiqui & Yousuf, 2012).  The terminology 
will be discussed later in the paper.      
  There is a multitude of information about Parkinson’s, ranging from its different stages to 
its life-changing emotions.  Such multitude includes the construction of PD, how it is made up 
and the problems affecting the area that leads to Parkinson, the symptoms which can be seen at 
an early age and seen upon a person.  Understanding the interpretation of the disease and an 
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individual is diagnosed, can range from symptoms being present to the use of diagnosing it using 
a measurement scales.  Medication is very important because it can be used to help keep 
symptoms under control and help with treating the symptoms.  Continued research is essential 
because there are a host of new, as well as old, diseases from which individuals are suffering.  In 
order to provide the most effective and promising services we need continuous research 
furthering background information on the diseases or disabilities.  Only when we have fully 
researched the disease and its effects on various individuals, can services be  
provided (Buck et al., 2010). 
Many people suffering from Parkinson’s disease have been documented as placing 
themselves in social isolation, later culminating in depression and in worse cases, suicide (Tuite 
et al., 2009).  It is imperative that this distressing scenario be addressed because there are many 
ways to deal with situations like this such as group therapy, seeing a psychologist or doctor.  
Social concerns are associated with many diseases and individuals handle their diagnoses in 
varying ways, leading to a myriad of obstacles.  
Table 1 
The potential needs of individuals with Parkinson’s disease      
 
 
 
 
 
As shown in table 1, these potential services could possibly be provided to those individuals with PD.  Individuals need services 
in order to get through some complicated times with their disease. 
 
Potential Needs of Individuals with Parkinson’s Disease 
Support Groups 
Counseling Services 
Case Management Services 
Therapy 
Vocational Assessments 
Palliative Care 
Individual Care Plan 
Assisted Living 
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Individuals with this disease are faced with obstacles every day, along with different 
interference that can affect their lives.  Some of these obstacles include vision problems, 
cognitive impairment, impact on emotions and life.  Vision problems can lead to motor 
functioning.  An individual with vision problems will have a hard time seeing, distinguishing 
colors, and not being able to see their family member and light sensitivity.  Vision is an obstacle 
for PD patient because this will not allow them to be capable of seeing.   
Cognitive impairment can later develop in the stage of PD, causing the patient not to 
respond well to the treatments and medications.  The situation can progress into a more 
complicated problem.  The impairment can affect memory and thinking within the brain.  
Depression, stress and medications can contribute  to these changes.  Emotions change 
throughout the stages of PD and medications can sometime be a factor to these changes.  Some 
medications can cause a patient to feel nausea, experience sleep problems, cause low blood 
pressure and confusion.  Levodopa, dopamine agonists (DA) and catechol-O-methyl transferase 
(COMT) can cause these different side effects within PD.   
According to the National Institute of Neurological Disorders and Stroke (NINDS), 
research is being conducted and research is being supported through grants to medical institute.  
Grants that are being administered are to help with additional research next to the National 
Institute of Health (NIH).  Researchers are working on new ways to improve drugs, therapies and 
treatments.  Research that is being conducted through the NINDS, are using test studies to 
develop new therapies and to better understand how the disease advances.  The FDA approved 
rasagiline in May of 2006 and approved it to be used alongside with the drug levodopa in more 
advance stages of PD (Schapira, 2011).      
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To better understand Parkinson’s, one must study the anatomy, pathophysiology, stages 
of the disease, differing types of related disorders, causes, symptoms (in-depth descriptions), 
diagnoses, medications, treatments, rehabilitation aspects, as well as the emotions exhibited by 
its elderly sufferers.  The ensuing research paper will offer insights to what Parkinson is, how it 
develops, and how it can be managed or controlled.  Parkinson’s can be a precursor to other 
disorders that affect its victims.   
This research is needed because it will provide information and understanding on how 
individuals are impacted by this disease and how RAS can provide services.  Many rating scales 
for PD have been used to determine the level of severity and the progression of the disease.  The 
main evaluation scales used for rating PD is the Unified Parkinson Disease (UPDRS), Modified 
Hoehn and Yahr scale, Schwab and England Activities of Daily Living Scale and Abnormal 
Involuntary Movement Scale (AIMS) (Palmer et al., 2010).  Literature will be provided on these 
different scales further in details.  These scales can also be given to family members who are 
impacted by this disease.   
The paper will contribute to insight on why it is important to know about this disease and 
how the Rehabilitation Administrator can improve services and programs. 
The objectives of the research are: 
1. Provide an understanding of what this disease is and historical facts. 
2. Provide knowledge and understanding of the impact that PD has on patients as well as 
the impact on their family members.   
3. Provide different coping mechanisms for handling PD.     
4. Provide information to individuals on how to manage obstacles that comes along with 
PD as the disease progresses.   
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The purpose of the paper is to provide more knowledge on PD as it is now.  Research is 
being conducted, with variables and factors associated with this disease is changing as well.  PD 
is one of those diseases that have been around for many years and scientist and researchers are 
trying to find a cure.  The following four areas are being investigated because it will 
accommodate the literature of PD and the overview of the disease.    
The purpose of the paper: 
1. Conduct research into the cause, treatments, medications and lifestyles of PD.   
2. Discuss the anatomy of this disease so there is a better understanding of how the 
disease influences a person psychologically and mentally. 
3. Provide different therapeutics to support a person with PD. 
4. Arrange information on cognitive, motor and psychiatric impairments for those with 
this disease.   
RAS goals/role is to achieve an individual independence, live more independently and 
provide support through counseling.  RAS can help these individuals who suffer from this 
disease by assuring the appropriate programs and services are being provided.  Services can 
include vocational rehabilitation, psychological services and individualized services.  Counselors 
are trained with classes and examinations on how to treat those with PD.  The proper educational 
classes can prepare a counselors and a RAS the tools for serving those with PD as well as others 
with different diseases or disabilities.  A counselor has to be certified in order to provide services 
and fulfill the services to those with PD and other diseases and disabilities.  Different institutes 
have different course work and requirements needed to fulfill one goal of becoming a counselor 
or a Rehabilitation Administrator.    
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Definitions of Terms: 
Akinesia- loss of motor function that leads to abnormal muscle movement (Merriam-Webster, 
2012). 
 
Anticholinergic- blocks the impulses through the nerves; it also blocks the combing 
neurotransmitter (Lindahl & MacMahon, 2011). 
 
Apathy- lack of interest or suppression of emotions or concerns for many things that other 
individuals find exciting (Buck, Trautman & Clark, 2010). 
 
Apomorphine- is in the dopamine agonist group; this drug is used to help with difficulty of 
movements, walking and sometimes speaking (Lindahl & MacMahon, 2011). 
 
Autonomic dysfunction- is a term that describes the malfunction of any disease (Merriam-
Webster, 2012). 
 
Autonomic Nervous System (ANS) - is a part of the nervous system that controls different 
actions, such as beating of the heart and blood pressure (Merriam-Webster, 2012).       
 
Basal ganglia- are a group of nuclei that that helps the brain function (Barone, 2010). 
Bradykinesia- extremely slows movement (Hermanns, 2011). 
Catechol O-methyltransferase (COMT) - is an inhibitor that is taken with levodopa.  A large 
amount of levodopa that goes to the brain causes the dopamine to increase due to this drug 
(Lindahl & MacMahon, 2011). 
 
Central Nervous System (CNS) - part of the nervous system that consists of the brain and spinal 
cord.  The brain and spinal cord serve as the development center and works all the body control.  
CNS receives messages as well as sending messages to the peripheral nervous system (Merriam-
Webster, 2012).     
 
Cognitive impairment- affects the ability to think and cause weakness of the memory and/or 
judgment (UCSF Medical Center, 2012).   
 
Compulsive behavior- is a behavior that occurs when an individual does not want to behave a 
certain way but they feel they have to behave in that order (Heisters & Bains, 2012). 
 
Corticobasal degeneration (CBD) - a neurological disease that is affiliated with brain 
degeneration, it also leads to loss of brain tissue within the cortex, causes cognitive dysfunction 
(Dalvi, 2012). 
 
Deep brain stimulation- a medical treatment that involves an electrical stimulus device to help 
control tremors (Heisters & Bains, 2012).   
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Dementia- loss of personality and intellectual capacity due to decrease neurons in the brain 
(Heisters & Bains, 2012). 
 
Depression- a mood disorder that causes sadness, anger and unhappiness that can affect daily 
activities of life (Merriam-Webster, 2012). 
 
Dopamine – a neurotransmitter in the central nervous system and the ganglia that help keep 
movement regulated (Heisters & Bains, 2012).   
 
Dopamine Agonists (DA) - stimulate the receptors that are in the nerves and it act like a 
dopamine (Heisters & Bains, 2012). 
 
Globus pallidus- is an output nuclei that receives other basal ganglia input and send output 
destination to the thalamus (Foltynie & Hariz, 2010).   
 
Glutamate antagonist- is used to treat symptoms of Parkinson; however, it is not a popular drug 
(Heisters & Bains, 2012). 
 
Hallucinations- sensing things and objects that appear real but instead, it is created in the mind 
(Merriam-Webster, 2012).  
 
Impulsive behavior- is a behavior that takes place based on tendency and acting quickly without 
thinking things through (Heisters & Bains, 2012).  
 
 Juvenile Parkinsonism- is a form of Parkinson disease that affects those under the age of 20 
(Hermanns, 2011). 
 
Levodopa- a substance that is used in treating Parkinson’s disease.  It crosses blood brain barriers 
that later turns into dopamine (Lindahl & MacMahon, 2011).  
 
Monoamine oxidase B (MAO-B) - are inhibitors that is used to treat depression (Heisters & 
Bains, 2012). 
 
Motor impairment- limitation in muscle movement and body movement (Usability Glossary, 
2012). 
 
Multiple system atrophy (MSA) - is a condition where similar symptoms as Parkinson’s occurs.  
MSA is more dangerous to parts of the nervous system that controls blood pressure and heart rate 
(Dalvi, 2012).   
 
Neurobehavioral- an assessment of a person state between behavior and the nervous system 
(Merriam-Webster, 2012). 
 
Neurons- impulses conducting cells that are the main function of the nervous system (Merriam-
Webster, 2012). 
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Neuropsychiatric disorders- a disorder that has psychiatric and neurological features (Merriam-
Webster, 2012). 
 
Pallidotomy- is a surgical procedure that is placed in the globus pallidus to abort small brain cells 
(Merriam-Webster, 2012). 
 
Parkinson Disease- a neurologic progressive disease of the Central Nervous System.  It develops 
over time and tremor becomes noticeable in the hands.  The condition becomes worse as time 
progresses.  The brain cells that produces dopamine later breakdown and self-destruct 
(Parkinson’s disease Foundation, 2012).   
 
Progressive supranuclear palsy (PSP) – is a Parkinson-plus syndrome that causes nerve cells that 
has been damage due to movement disorder (Dalvi, 2012).   
 
Reinforcement learning- learning new things by interacting within the environment (Merriam-
Webster, 2012). 
 
Social isolation- lack of interaction with different people, environment and social conversation 
Portillo & Cowley, 2011). 
 
Social rehabilitation- process which an individual becomes aware of his or her social limitations 
and later develop coping mechanisms to help him or her to enjoy social life situations (Portillo & 
Cowley, 2011) 
 
Striatum- is the largest nucleus within the basal ganglia (Merriam-Webster, 2012).    
 
Substantia nigra- a pigmented area within the midbrain that has dopamine producing nerve cells 
(Foltynie & Hariz, 2010). 
 
Subthalamic nucleus- the second most important input nucleus to the basal ganglia (Foltynie & 
Hariz, 2010).   
 
Thalamotomy- is a procedure that destroys a portion of the thalamus (Merriam-Webster, 2012). 
 
Thalamus- is part of the brain that sends sensory impulses to the cerebral cortex (Merriam-
Webster, 2012). 
 
Tremor- shaking of the body, limbs from a disease that can cause weakness (Merriam-Webster-, 
2012). 
 
Unified Parkinson’s disease Rating Scale (UPDRS) - is a scale that rates the course of 
Parkinson’s disease and is categorized into five sections (Palmer et al., 2010). 
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Summary of Chapter 1 
 
 Many terms including compulsive behavior, depression, the Central Nervous System 
(CNS) and dementia has a specific meaning with PD.  Based on any research, there are many 
terminology associated with different diseases or disabilities.  As an RSA, research does not stop 
at the terms but provides accurate services and programs.  Just alone from the previous chapter 
individuals with this disease are faced with obstacles everyday along with different interference 
that can affect their lives.  Having the appropriate knowledge, can be used to help those who 
have fallen victims of this disease.  In addition to having the knowledge, knowing the terms are 
essential because they will help you have a better understanding of PD and how to distinguish 
between one symptom and another one.  The research may be of a great deal of importance in 
providing this literature to individuals that has suffered from PD.  
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CHAPTER 2 
OVERVIEW OF LITERATURE 
Parkinson is a condition that date back to ancient times.  According to the Western 
medical literature, physician Galen described it as the “shaking palsy” in 175 A.D.  However, an 
Englishman and London doctor named James Parkinson, who in 1817 described the disease in 
his detailed essay, entitled “An Essay on the Shaking Palsy (Goetz, 2011).”  After this essay, 
Parkinson’s disease was recognized as a medical condition.  Mr. Parkinson essay was based on 
three of his patients he observed for himself in his practice and three people that were around his 
neighborhood.  The essay held descriptions of the disease symptoms and his theory that the 
problem was in the medulla of the brain.  The purpose of the essay was encouraging other 
individuals to study the disease in more details.  After 60 years, Jean Martin Charoot a French 
neurologist studied more about the disease.  Mr. Charoot was the first to see the importance of 
the disease and the first to name it Parkinson’s disease after James Parkinson (McCoy, 2009).     
In the 1940s and 1950s, surgery was conducted on the basal ganglia of the brain, which 
proved to be helpful because improvements were shown, based on those who had the symptoms 
(McCoy, 2009).  The Parkinson’s disease Foundation was founded in 1957 (Parkinson’s disease 
Foundation, 2012).  The foundation’s mission was to help those who suffered from PD and to 
help fund the foundation for further research, which led to other organizations and foundations to 
help with identifying the causes of the disease.  In the 1960s, it was identified that those with 
Parkinson’s had a chemical indifferences in their brain (McCoy, 2009).  Research on the disease 
has increased phenomenally.  Since there is no cure for Parkinson, the symptoms itself needs to 
be controlled with the different medications and treatments. 
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Progression of Parkinson’s Disease 
Parkinson disease is a chronic (long duration) progressive degenerative (declining in 
quality) neurological disorder that affects the way an individual move and the Central Nervous 
System (CNS) (Hermanns, 2011).  Parkinson’s influences the speech motor skills and 
coordination of an individual.  PD is a complex condition that can results in distressing and 
disabling symptoms (Johnston & Chu, 2010).  PD also affects a person socially, biologically and 
psychologically.  It is also affiliated with a group called motor system disorders (Buck, Trautman 
& Clark, 2010).  This particular group is involved with lose of dopamine that produces brain 
cells (Hermanns, 2011). 
 Parkinson’s occurs when there is a problem with a nerve in the brain.  With the disease, 
the nerve cells (neurons) are known as substantia nigra.  Substantia nigra is mostly affected when 
the brain has the ability to generate movements.  It is then interrupted by the neurons in the 
substantia nigra.  Dopamine is a chemical in the brain made from the nerve cells that are 
destroyed (Heisters, 2012).  Dopamine controls muscle movements in the body (Bains & 
Heisters, 2012).  Without the correct amount of dopamine, the brain messages cannot be sending 
appropriately.  Action of dopamine and decrease stimulation of the motor cortex is important 
when symptoms appear.   
Prevalence of Parkinson’s Disease 
Yearly about 60,000 Americans and 7 to 10 million people worldwide are diagnosed with 
Parkinson.  Approximately, one million people alone in the United States have PD and many 
cases are unknown or undetected (Parkinson’s Disease Foundation, 2009).  An exact count of 
Parkinson is impossible because some people with the early stage symptoms thinks it is a result 
of regular aging based on the Parkinson’s Disease Foundation.  The disease is about 50 percent 
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higher in men then in women (Hermanns, 2011).  The average age for this disease to become 
recognized is 60 years old and it gradually increases with age.  With the increase of age, new 
cases affect one percent of people older than 60 and three percent older than 85 (Hermanns, 
2011).  The information stated is important because people need to have an idea of when this 
disease occurs and who is infected.  Having the correct knowledge, one can prepare a person 
over the age of 60 and up of what to expect.  The information can help an individual live more 
effectively with this disease.  If there are any signs leading up to this disease the individual 
family and readers can have information on what is next for this disease.     
 The first appearance of the disease occurred between the ages of 50 and 60.  Over 10 to 
15 years of age the disease increased disability.  Early on-set Parkinson is shown before the age 
of 50 and about 5 to 10 percent of people with it have early symptoms (Hermanns, 2012).  An 
early stage of the disease is inherited, sometimes not always but it has been showed to be due to 
a specific gene mutation.  Juvenile Parkinsonism is a condition where Parkinson symptoms occur 
before the age of 20.  According, to some researchers, it is a higher case in developed countries.  
This is so because toxins are in those developed countries and have very high exposure to 
pesticides.   
     Biological Construction  
The construction of this disease is predominantly based on the basal ganglia (Foltynie & 
Hariz, 2010).  Basal ganglia are a group of functionally strong nuclei that helps with the motor 
function as well as the emotional behavior and cognitive function of the forebrain (Barone, 
2010).  The basal ganglia are connected with different areas of the brain such as the thalamus and 
the cerebral cortex (Foltynie & Hariz, 2010).  These disruptions analyze numerous symptoms 
that occur in this disease.  The disruptions also affect the movement and attention process 
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(Foltynie & Hairz, 2010).  Reinforcement learning and Pavlovian behavior responses are 
believed to be linked to a set of functions that affects the ganglia (Barone, 2009).  The high 
levels of dopamine are what keep the coordination of the body movements together.  As the 
levels decreases it allows for symptoms to develop even further and new symptoms makes 
appearances in the individual (Barone, 2009).   
 The ganglia have four main components that make up the area: striatum, substantia nigra, 
globus pallidus and subthalamic nucleus (Foltynie & Hariz, 2010).  Of the four components, the 
striatum is the largest.  It appears in the center part of the ganglia.  The striatal circuits are 
important because it demonstrate a high quality of cognitive behaviors as well as complex motor 
behaviors.  
Substantia nigra reticulate and globus pallidus internus are believed to be a link between 
the development of the thalamus and the hypokinetic of PD.  Globus pallidus internus and 
substantia nigra reticulate causes abnormalities, which causes different motor areas in the cortex 
and thalamus to become active.   
Stages 
Parkinson’s Disease is consists of five progressive stages.  An individual can progress 
through these stages in order or skip stages depending on the progression speed.  This decision 
will help the individual family become aware of the treatments and have a knowledgeable 
understanding of the condition, how it develops and progresses.  As the stages, escalate the 
symptoms increase.   
The Parkinson disease stages, includes administering different medications based on an 
individual symptoms, support and rehabilitation.  The medications that are being provided are to 
help produce more activity within the brain.  Taking the right medications can increase 
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independent function, not only in the body but also in the muscles and movements.  The 
rehabilitation team is to help individuals with self-care, activities and devices (if necessary).  The 
rehabilitation counselor provides insight and stability on treatments the individuals has received.  
The role of the RAS is to provide necessary programs or services to help those individuals 
become use to any devices they are using and help the individual is more comfortable with using 
the devices.   
Psychological counseling is to help individuals deal with different emotions such as 
depression, isolation and hallucinations that can occur from time to time.  These emotions can be 
side effects of the medication or just the individual.  Many cases of PD such as dementia and fear 
of disability can have a person go through withdraw with their surroundings.  Those caring for 
these individual should be familiar with the symptoms, treatments and side effects of PD so the 
family can provide comfort to that person.  Manual dexterity can be a vocational challenge for 
someone with PD.  Depending on the occupation, a few patients can return to work based on the 
severity of his or her prognosis.  A vocational counselor can help determine what sort of work 
can be done or achieved.   
Stage One  
Stage one, is the beginner stage of PD.  Generally, an individual in this stage has very 
mild symptoms but they show no sign of having this disability.  Tremors and shakiness is the 
first sign of symptoms in this stage.  Some family and friends can see changes in the individual’s 
posture, facial expressions and their balance.  Present symptoms can affect everyday activities 
within this stage.   
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Stage Two 
 Stage two, is the mild to moderate PD.  The individual with the disease starts to have 
bilateral symptoms on both sides of their body.  Posture and their walking ability become more 
noticeable.  Individuals will start having signs of rigid muscles that can cause pain.  Arrival of 
the symptoms set off disturbance of daily living and activities.  Completing tasks in this stage 
begin to appear noticeable. 
Stage Three  
Stage three, is the moderate stage.  Individuals in this stage show clues of body 
movements slowing down.  The function of this stage is independently stable.  Tremors and 
rigidity muscles can become defective as time moves on.  The equilibrium can show early 
impairment signs immediately upon standing or walking.  Speech problems, smiling or blinking 
are more evident in this stage.   
Stage Four 
 Stage four, is the advanced stage.  Assistance may be needed in this stage. While the 
symptoms become extremely noticeable, this blocks the person ability to maintain a decent life 
and care for them.  Stage four patients can still walk to some degree.  The tremors are still in the 
person but not severe.  Body rigidity can be unrelenting.  Dementia debut in this stage.   
In Parkinson, dementia has been referred to as the cognitive impairment.  After an 
individual has been, diagnosed with the disease as lease one or two years later, the patient will 
develop some signs of dementia.  Loss of thoughts, memories and disorientation are the common 
sign of dementia.   In Parkinson, dementia has been referred to as the cognitive impairment and 
takes place in the later stages of the disease.  It alters the language, memory, social judgment, 
mental skills and reasoning.  Confusion is a main issue with the patients.  Confusion can become 
16 
 
 
 
worse at night and eventually develop into hallucinations or delusions.  Communicating with the 
patient with these symptoms it is imperative to speak clearly and calm.   
Stage Five 
Stage five, is the disabled stage.  This stage is the disable stage because mental and 
physical ability declines.  Individuals cannot walk or stand in this stage and are usually bound by 
a wheelchair.  At this stage, it takes over bodily movements and muscle use.  Consistent care is 
needed around the clock.   
 One in three Parkinson patients will develop some forms of dementia.  Approximately, 
80% of the patients will have some symptoms after they have been diagnosis with Parkinson 
(Heisters & Bains, 2012).  Corticobasal degeneration (CBD), multiple systems atrophy (MSA) 
and progressive supranuclear palsy (PSP) is common disorders that are a part of Parkinson-plus 
disease (Dalvi, 2012).  In some cases Parkinson-plus is more rapid than the typical Parkinson 
(idiopathic) is (Dalvi, 2012). 
Hallucinations affect about one-half of individuals with Parkinson.  Hallucinations can 
affect one of five primary senses, which are odorous (smelling), visual (seeing things), gustatory 
(unusual taste), auditory (hearing) and tactile (skin feeling sensations).  Patients with the disease 
sometimes have hallucinations, which are usually a visual one.  Commonly known to take place 
in the early morning or late at night, when the person wakes up in the morning or when the 
person gets ready to fall asleep.  Some people having these hallucinations have a hard time 
distinguishing hallucinations from reality.  Once the patients start to believe the hallucinations 
are real, they are considered delusional.  Delusions and hallucinations are considered psychotic 
symptoms of Parkinson (Siri et al., 2010).   
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Symptoms 
Like any other disease, not every patient has the same symptoms at the same time.  
Symptoms differ with each patient based on which stage they are in.  It can take about 20 years 
to see symptoms in some individuals and some may have the rapid symptoms (where you can see 
them early).  Meanwhile, symptoms start becoming more evident on one side of the body, based 
on the complex of the symptoms and how they progress into complications that are more serious.  
Once the symptoms become more evident physical appearance starts to decline.    
 The primary symptoms of this disease are slowness of movement, rigid muscle stiffness 
(sometimes-freezing muscle stiffness).  Loss of physical movement (akinesia), tremors and 
slowing of physical movement (bradykinesia) are the main components of the motor symptoms 
of PD.  Not every patient will experience tremor, more than half the patients will have this 
experience. The disease advances slower as movements decline as well.  
Tremor is an involuntary shaking of the body or limbs commonly seen in the hands arms, 
legs and voice.  Stress and anxiety are top factors that can cause the tremors to become worse.  
Due to the muscle pain it can hinder stretching and relaxation.  Tremors can make it difficult to 
complete daily living activities.  Due to problems within the brain that controls muscle 
movements, tremors appear in such areas that were previously stated.   
Depression and pain can affect a person’s daily activity.  Depression is the common 
problem that people with PD has.  There are approximately, 50% of PD patients diagnosed with 
depression.  Physicians believe that depression is part of the disease process.  Depression can be 
treated with antidepressant medications.  Seeking the medication can make it easier in coping 
with Parkinson’s.  Pain is a terminology that develops when the joints and muscles begin to ache 
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due to movements.  Pain is associated with the rigidity symptoms and abnormal postures.  Many 
exercises can help with aching joints and muscles.   
Nonmotor symptoms have a comprehensive extension of symptoms.  Autonomic 
dysfunction, neurobehavioral problems, neuropsychiatric disorders and sensory disturbances are 
just among the symptoms.  An indispensable process called pathophysiologic causes nonmotor 
symptoms.  Nonmotor manifestations can develop in prime and later PD.  Fatigue, sleep 
disorders, constipation, swallowing and sweating and apathy are common nonmotor symptoms 
(Heisters, 2012).   
Sleep problems affect many individuals with Parkinson’s.  The patients can wake-up very 
frequently throughout the night and have problems going to bed.  After three or four hours of 
sleep, a person wakes up feeling as if they had a full night of sleep.  Some patients may have a 
sleep attack where they just fall asleep suddenly.  Emotional dreams and nightmares can occur 
during sleep problems.  The most dangerous act a PD patient can do is taken over the counter 
drugs without consulting with their physician.  
Bowel and bladder problems can work improperly due to the autonomic nervous system 
(ANS).  The autonomic nervous system provides an individual smooth muscle activity (Bains & 
Heisters, 2012).  Constipation is due to poor eating diet or not drinking enough fluids.  Some 
medications used for the disease can cause constipation problems.  The bowel and bladder can 
lead to urine retention.   
Chewing and swallowing often becomes difficult to achieve.  The muscles you use to 
swallow may become problematic in the later stage of Parkinson.  Swallowing becomes difficult 
and eating becomes a challenge.  Saliva and food can back-up in the throat causing the individual 
19 
 
 
 
to choke or drool.  Prior to determining if swallowing is a problem, the patient would need to see 
a speech pathologist.   
Apathy is an absence or suppression of passion, excitement or emotion.  It lacks interest 
or concern for things that others find exciting or moving.  Apathy is considered a sample for 
nonmotor symptoms and goes beyond behavioral, affective and cognitive concerns.  In addition, 
it also slows down the fulfillment of daily living.  Lack of productivity, effort and dependence 
are factors that contribute to behavioral concerns (Buck, Cark & Trautman, 2010).  Inadequacy 
of response leads to positive or negative thoughts or actions.   
Interpretation 
Diagnosing PD is based on the individual’s medical history and their symptoms that are 
present.  Examinations are for observing and interviewing the patient to understand what types of 
symptoms has developed.  Motor movements, reactions and muscle reflexes are involved in this 
examination.  The doctor will check your vision, your muscle reflexes and strength.  No test has 
been produced to diagnose this disease.   
Two of three symptoms have to be present at the time of diagnosis, which is tremor at 
rest, rigidity and bradykinesia (Heisters, 2012).  Tremor is based on the inspection of the 
movement.  The rigidity testing is the movement of the upper limbs, head, neck and lower limbs.  
Bradykinesia involves extremely slow movement and is based on how fast you can tap your foot 
up and down and how fast you can tap your fingers together.   
While assessing them, the patient has to be relaxed and comfortable.  Postural instability 
(Antonini et al., 2010), which is sometimes called impaired balance/posture, is referred as the 
pull test.  Physician checks your balance in this assessment.  The physician stands behind you 
and gently pulls you backwards to see if you maintain balance without falling.   
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One technique used to diagnosis Parkinson’s and measure its progression is the Unified 
Parkinson’s Disease Rating Scale (UPDRS) (Palmer et al., 2010).  The UPDRS is used to check 
how severe the symptoms are within the disease.  While patients took the examination, 
administrators saw for themselves if there were any abnormal behavior such as shaking or body 
movements.  The scale is compounded of four components phase one mentation, behavior and 
mood, phase two activities of daily living, phase three motor examination and phase four 
discussing the complications (Kleiner-Fisman, Stern, & Fisman, 2010).  
Medication 
As the disease progresses over time, different treatments will be needed.  Treatment and 
effects are different among everyone with Parkinson’s.  Symptoms varying among people, 
doctors will begin to prescribe drugs when the symptoms begin to surface and affect daily 
activities.  The overall goal of medications is to treat the neurotransmitter.  Each patient will 
have a carefully well thought out medication plan to help control their symptoms.  If patients do 
not receive their medications on time, various consequences can occur.  A huge consequence of 
not receiving medications is the ability to walk or move which could be problematic.  Some 
treatment for early on-set Parkinson’s are levodopa, dopamine agonists (DA), apomorphine, 
anticholinergic, monoamine oxidase B (MAO-B) inhibitors, glutamate antagonist and catechol-
O-methyl transferase (COMT) inhibitors.   
Levodopa is the main medication used to treat symptoms and signs for Parkinson’s.  This 
particular drug works more effectively than any other drug.  The drug reinstate the dopamine that 
was absent in the patient (Lindahl & MacMahon, 2011).  Levodopa can be issued at any stage of 
the disease (Bains & Heisters, 2012).  Levodopa dispenses aid in life expectation, daily living 
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and aspect of life.  Patients will later struggle with dyskinesia and motor fluctuations after being 
on the drug for so long (Antonini et al., 2010).  
Dopamine receptor agonist can postpone motor fluctuations from surfacing.  About 40-
50% of the patients that had treatments over five years will have some form of motor 
complications that comes to surface (Antonini et al., 2010).  About 80% of those patients who 
were treated over ten years will have motor complications happen to them.  According to 
Antonini (2010) explained “three potential mechanisms have been proposed to explain the 
development of motor fluctuations in levodopa-treated patients.” These three mechanisms are 
peripheral factors such as impaired gastric emptying and competition with dietary protein for 
levodopa absorption; presynaptic factors related to nigrostriatal dopaminergic neuron loss and 
subsequent handling of levodopa by other neuronal and glial cells; and postsynaptic and 
downstream changes occurring as a results of pulsatile stimulation of dopamine receptors.   
(p.121)  
Even though the drug works better, there are still negative side effects.  One possible side 
effects is where the body becomes slow and very stiff to move around.  Dyskinesia is the 
abnormality of voluntary muscle movements and is another possible side effect that can occur.  
Loss of appetite, sleepiness, vomiting, hallucinations and psychological problems are common 
side effects to this drug.  The goal of this drug is to control the symptoms and keep the side 
effects to a minimum.  
Dopamine agonists (DA) are another common drug used for the treatment of this disease.  
Dopamine agonist acts as a stimulus for the dopamine receptors (Lindahl & MacMahon, 2011).  
Just like Levodopa, the drug can be prescribed at any time in Parkinson’s.  Occasionally, DA can 
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become less sensitive to the receptors.  Sleepiness, low blood pressure, stuffy nose and 
constipation are among the side effects of this drug.   
Apomorphine is a major drug among DA (Lindahl & MacMahon, 2011).  The drug acts 
fast to treat rare episodes of immobility with PD.  Apomorphine is a drug that is injected when 
the muscles are frozen and you are unable to do your regular daily activities.  Receiving this shot 
can reduce the regular amount of medications you are taking.  Patients that take dopamine 
agonists can possibly have compulsive and impulsive behaviors as a side effect.  Compulsive 
behavior is an act, which the person does not want to do things but do it anyway because they 
feel the need to.  Impulsive behavior is where individuals act quickly to certain events without 
thinking or taking the right precautions.  These behaviors are the undesired side effects of 
apomorphine and they can cause harm to the patients.  If these behaviors are even suspected of 
happening with a patient, action has to be done.   
Anticholinergies has been around for several years to help the tremor in Parkinson’s.  It 
sends information from the nerves to the muscles to allow movements.  Anticholinergies best 
works in the early stage of Parkinson when the symptoms appear mild and calm (Bains & 
Heisters, 2012).  It can become problematic to withdraw from this drug.  Lindahl and MacMahon 
suggest that this medication is no longer recommended but at some time, it was used for 
treatments.   
Monoamine oxidase B (MAO-B) inhibitors are another dopamine that breaks down the 
secreted dopamine (Bains & Heisters, 2012).  The enzyme that breakdown are called monoamine 
oxidase type B (MAO-B) (Lindahl & MacMahon, 2011).  This inhibitor can be taken alone or 
among other drugs that helps with the disease.  Patients taking these inhibitors and other drugs 
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should be aware that it could cause the blood pressure to rise.  Some side effects include 
insomnia, aching joints, depression and severe headaches.   
Glutamate antagonist is not a common drug used for the disease.  However, it can be used 
for treating dyskinesia’s, rigidity and tremors.  Amantadine is a glutamate antagonist drug that 
slows down the dopamine activity (Lindahl & MacMahon, 2011).  This drug can cause confusion 
and hallucinations.  Bains and Heisters suggest that glutamate antagonist and amantadine are 
used infrequently and that a patient would not likely come across these medications.   
Catechol-O-methyl transferase (COMT) inhibitors are used with levodopa (Lindahl & 
MacMahon, 2011).  These inhibitors help keep the disease symptoms under control.  The 
inhibitors help the enzyme to breakdown the levodopa in the patients system (Bains & Heisters, 
2012).  Side effects include chest pain, dizziness and confusion. 
Therapeutics 
Even though there is no cure for Parkinson’s there are some surgical procedures an 
individual can seek out.  Before the drug Levodopa was discovered, surgery was the common 
treatment for PD.  Since Levodopa is the new treatment, surgery was only considered for a few 
people with Parkinson’s.  Surgery was only used if the individual did not respond well to the 
drugs being used and for those who had more advance Parkinson’s.  Some surgical procedures 
include deep brain stimulation, pallidotomy and thalamotomy.   
Non-drug therapies are also good for patients.  These types of non-drug therapies had a 
positive influence of individual’s daily activities (Heisters, 2012).  It is, important that the 
patients have a unique designed therapy program that can help with motor, balance and 
movements.  A dietician can be an advisor for someone with PD.  The dietician can consult for a 
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healthier diet.  Managing symptoms through non-drug therapies can improve regularly daily 
activities.    
Deep brain stimulation (DBS) is the most common late symptoms neuro-surgical 
procedures (Lindahl & MacMahon, 2011).  This type of treatment is surgically implanted into 
different parts of the brain by an electrode.  Pulse generator (PG) is an electrical device the 
doctor use to put under your skin to send stimulation pulses to the brain that can help sub come 
different symptoms of PD (Heisters, 2012).  PG can also be used on the right or left side of the 
brain.  DBS stimulates one of three brain parts: the thalamus, globus pallidus and the 
subthalamic nucleus.  The most common area among these parts is a tiny section under the 
thalamus. 
This stimulation help reduce tremor, bradykinesia and rigidity the subthalamic nucleus 
and the globus pallidus.  In some cases, DBS lower the need for other drugs and Levodopa, 
which can lead to a reduction with involuntary movements.  However, the stimulation does not 
help with speech problems.  The stimulation can help improve quality of life, sleep, stride length 
and velocity.  About five percent saw a difference in this procedures then they did using the 
medication.  The symptoms and movements of PD are improved over time.   
Murdoch (2010) stated that, “Pallidotomy and Thalamotomy were surgical procedures 
within PD.  Between the two procedures, Pallidotomy was the most common.  Furthermore, 
pallidotomy disrupts the connections between the thalamus and the globus pallidus, improving 
the common symptoms of rigidity, tremor and bradykinesia.” (p. 61) According to researchers, it 
helps reduce the amount of Levodopa that some patients may need.  The primary goal of the 
thalamotomy is to remove part of the brains thalamus and to help reduce the tremor that occurs.   
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A person with the disease have symptoms that can change on a daily basis and some of 
the side effects of the drugs being taken can slow down there activity and movement.  A physical 
therapy, physiotherapy, occupational therapy and speech therapy plays an important role with 
someone that has the disease.  This therapist has responsibilities as being an individual that help 
those overcome physical impairments.  These impairments are discussed with their appropriate 
therapist.    
Physical therapy can help deal with exercises and stretches that can loosen the muscles.  
Exercises can improve flexibility, posture endurance and strength.  Exercising is important and it 
helps people with PD also, it helps with the early and latest stages of PD as well.  Daily exercise 
can help increase endurance, control weight improve range of motion and flexibility, reduce the 
risk of being constipated, maintain coordination and muscle strength and improve cardiovascular 
fitness.  It is known that exercises can improve your mood, confidence and give you a sense of 
well-being.   
Physiotherapy provides techniques for handling movements more easily based on 
evaluation (Bains & Heisters, 2012).  These techniques can be taught early or late in the stages.  
Massages and special exercises can be a lot more helpful and useful weather then using drugs.  
Daily activities can become more easy and improved through the correct and proper 
physiotherapy.  Implementing patient education is important to physiotherapy.   
Occupational therapy (OT) help patients cope and plan more effective movements in their 
daily living activities.  OT can take the pressure off those family members who are caring for 
those who have the disease.  Some activities can include dressing, combing your hair, writing, 
bathing and cooking.  Treatment through OT can take place through all stages of the disease.  OT 
goals are to help improve your balance, strength and walking just as a physical therapist would.  
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They also help assist with using walking devices (walkers and canes) properly.  In addition to 
assisting with devices, they also evaluate home safety precaution to help reduce risk of falling.  
Changes that a person may need an occupational therapist can assist them.   
Speech therapy is to help patients with their speech and the way they communicate with 
other people.  With the disease, your speech can become soft and you start to lose your voice.  
The therapist helps with problems in such areas as vocal quality, articulation intelligibility and 
voice loudness.   Different techniques can help improve or strengthen the patient’s voice and 
their communication.  About half of the patients with this disease experience some form of 
communication problems that has to be address.   
The goal of the speech therapist is to make sure the patient overcome the softness of their 
voice.  The therapist also develops speech and breathing exercises.  The therapist will help you 
design ways to help you with your speech such as exercising your speech so you can sound 
clearer, exercising to help you practice your pitch changes when you communicate, breathing to 
improve your voice and different ways to keep your speech rate regular.  Techniques can be 
established to help with these problems.  The therapist can assess for dysphasia and help the 
patients with recommendations for preventing aspiration.   
Exercises are the most important key to any diseases.  It improves quality of life and 
increases the individual mobility.  Exercises decreases muscle cramping but improve motor 
movements.  Anxious and depression mood can become better doing exercises.  Before any 
exercises can be conducted one need to consult a physician.  Numerous exercises can increase 
better mobility in the arms, legs, hands, wrist, face, shoulders and muscles (Georgy, Barsnley & 
Chellappa, 2012).  Exercises can decrease symptoms and lead to a healthier lifestyle.  Some 
techniques that can help with balance and flexibility are Yoga and Tai Chi.   
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Exercising programs can be designed for each patient with the help of a Physical 
Therapist.  The PT will evaluate your current state and certain exercises you can already do.  
Once the PT has everything they need from the evaluation then a safe and professional plan can 
be established.  The program can focus on balance difficulties, muscle pain, problems with 
bathing, writing, dressing and issues walking or maintaining mobility.  If the patient has a 
caregiver then the PT will teach the caregiver how to do the exercises.   
Due to changes in the body, individuals coping with long-term disease suffer greatly from 
social isolation.  Social isolation can affect relationships within families, a family framework and 
lives.  Social rehabilitation is a process that takes place during long-term affliction.  Social 
rehabilitation is the process through which a person becomes aware of his/her own social 
limitations and consequently, develops activities to cope with and enjoy social life situations in 
familiar and/or other environment (Portillo & Cowley, 2011).  Social needs have to be address 
and handled during the initial stages of Parkinson or else the problem will not subside.  The 
socializing aspects can have success while it can cause relapses.   
Social rehabilitation is grouped into three categories in order for this rehabilitation to 
occur; they are internal criteria, active behavior criteria (ABC) and external implications of 
social rehabilitation (Cowley & Portillo, 2010).  Internal criteria deals with cognitive and 
psychological internal issues that patients and their families go through in order to establish a 
positive outlook on social life.  Patients had to adapt to their physical self and their disability 
they had, establish their social concerns and draw a line between their social activities and their 
disability problems.  ABC is used to promote social activities that patients are faced with every 
day.  This criterion takes place after the internal criteria.  ABC is related to the patient 
accomplishment of socializing and enjoying the social life benefits.  For these items to be 
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effective patients had to continue having a healthy social affiliation, arrange social decisions as 
well as choices and just enjoy any activities.  External implications of social rehabilitation were 
for patients and their caregivers to make other individuals aware of any activities that were being 
completed in an appropriate way.     
Support 
Support groups are a form of coping.  Other individuals and their families that have PD 
can help you understand the disease much better.  These groups provide comfort and confidence 
to talk about problems and feelings.  Some people go because they need help or more support 
other than from their families.  Not only receiving valuable information from the group but also 
different ways to cope with PD from other individuals and how they cope with PD and/or some 
other diseases can be beneficial.  Therapist plays an important role on the impact of Parkinson’s, 
helping families and individual cope with a disease.   Education courses can be conducted to help 
with understanding the disease, medication and there side effects, symptoms overview and the 
stages.   
The caregivers play an important part of the patient life so the courses are very vital for 
them.  Caregivers have to provide social and psychological support to the person they are caring 
for (McLaughlin et al., 2010).  Sometimes caring for a family member can be difficult and 
sometimes beneficial all because support is being provided.  Many burdens come with being a 
caregiver for example stress, which is a common burden.  Stress comes from a numerous of 
problems such as physical and emotional sources.  Everyday problems such as caring for an 
individual, financial problems and fear concerning the family member with PD future can cause 
stress (McLaughlin et al., 2010).  It is important to remain focus and relax when dealing with 
these problems.  Stress management can have a big impact on those who are under stress.   
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Once the illness start becoming more progressive and the elderly get up in age, the 
caregivers feel they have to accommodate more emotional, physical and social support 
(McLaughlin et al., 2010).  These accommodations can lead to distributing medications, personal 
care and driving them around.   Limitations of accommodating those with PD are financial 
issues, doubts for the future and depression.  Information has to bestow on the individual who is 
caring for the person with PD.  The information includes identification, effects of PD, 
medications and side effects.   
Life goals are beneficial to have especially for someone with Parkinson’s (McNamara, 
Durso & Harris, 2006).  A chronic illness can cause a patient not to worry about things that are 
going on around them but focus more on the negative aspects.  It can be very helpful against 
mood disorders and depression.  Elderly, worry about life but with life goals they can live a 
healthy life.  An elderly living with a disease or have an illness can affect their thoughts on their 
life and cause them to think negatively.   
There are numerous inventories that can measure where a person mood, anxiety, 
depression are at.  The Rivermead Life Goals Questionnaire was designed to have an outlook on 
where the importance of life goals lies.  It could be difficulties in their life activities, hobbies or 
arrangements.  The Scales for Outcomes in Parkinson’s disease (SCOPA) is a battery test used 
for assessing nonmotor and motor symptom (Buck, Trautman & Cark, 2010).  The scale checked 
for cognitive dysfunction, depression and pain.  It also addressed daily activities of life.  The 
Medical Coping Modes Questionnaire (MCMQ) is used to assess coping (Evans & Norman, 
2009).  The MCMQ questionnaire was to help measure coping and see exactly where the coping 
mechanism lies.   
 
30 
 
 
 
Summary 
An obstacle an RSA could face is developing the right program for a patient.  Every 
patient will not have the same symptoms as someone else.  Provided with the correct knowledge 
and understanding there is a key place to begin with treatments.  Many medical individuals are 
involved with PD.  These medical individuals have roles to maintain and provide the right 
information and guidance.  PD comes with several information and ways to cope with this 
disease.  In latest news, exercise is improving mobility and keeping PD patients fit.  Different 
types of exercises such as stretching, working on the treadmill and developing a workout plan is 
beneficial.   
Once the symptoms have been identified, treatments can begin on each staff part.  After 
these symptoms have been identified then necessary, resources can become available and used.  
Family members, not just those who are affected with this disease play an important part in any 
disease.  These family members provide the support that the diagnose patient needs to help get 
them through rough times.   
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CHAPTER 3 
DISCUSSION AND IMPLICATIONS 
The goal of this research was to identify different obstacles among individuals with 
Parkinson Disease and ways to handle these obstacles, understand the medications, treatments 
and the impact it has on someone with PD and their emotions.  Particular information can be 
useful with what type of services the individual may need.   
  Social isolation is the lack of interaction with different people, environment and social 
conversation.  With patients being diagnosis with this disease and sometimes not having the 
proper knowledge of PD, most patients think they are going to die.  With this thought, it causes 
those to separate themselves from family members and social events.  Isolation can lead to more 
concern in addition to the disease.   
Group therapy is a main key factor in guiding an individual through social isolation.  
Some support can come the National Parkinson Foundation.  The National Parkinson Foundation 
(NPF) ensures that PD individual is provided with the best possible care and knowledge of the 
advancing disease.  The NPF provides counseling to help those dealing with isolation and 
depression.  The treatment the NPF is utilizing is physical and psychological therapies.      
Talking with someone that is going through this issue can be beneficial.  He or she can provide 
insight on the disease and how to live with it and how to continue to be socially active and self-
involved.  The individual can provide support as well as guidance into what aspect of the disease 
is crucial to focus on. 
Parkinson is one of many diseases that are yet to have a cure but research is still being 
conducted to find this cure.  With the disease having a major impact on those over 65 years old, 
support is the main key to help an individual get through these hard times.  With older 
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individuals, they need plenty of support and care based on how severe this disease has become to 
them.  The literature that was provided was to illustrate an in-depth closer look at the disease.  
There is an understanding of how this disease progresses, the effects it has on someone body and 
their movements.    
Education and knowledge on how to help those with PD can be received at a higher 
education and in training.  Training can be provided in the clinics, physician offices, hospitals 
and treatment centers.  On-the-job training is needed because there are equipment’s, documents 
and materials that can have a positive impact on becoming more familiar with the employment 
position.  On-the-job training is more effective because you have hands on tools as well as 
working situations.  Orientation training is a training that every new employee goes through.  
Previously mentioned, orientation training is provided to help employee develop their skills and 
interpersonal skills.  Internship training can also be provided through undergraduate and graduate 
education.  Internship training provides the basic knowledge for fulfilling the employment as 
well as gaining knowledge about the position and the requirements.    
Counseling sessions can also help those who are working with patients with PD as well 
as help them with managing their obstacles.  Research on the disease can help an individual 
become more familiar with PD.  This can allow someone to have some knowledge of what PD is 
and whom this disease infects.  Experiences are needed in order to provide the right assessments, 
treatments and services.  Counselors or therapist can provide different methods in handling 
obstacles.  These methods can include motor improvement (gaining strength in arms or legs) and 
mental improvement (overcoming depression and social isolation).   
RAS’s, main duty is to support and serve those with disabilities through effective 
programs and services.  These RAS’s also oversees grant programs that can help individuals live 
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more independently through counseling, development, competitive employment, psychological 
and medical services.  Grant programs provide funds to state agencies and rehabilitation centers.  
Vocational rehabilitation is a crucial part of RAS.  The vocational rehabilitation is what 
determines what types of services are needed (individualized services or job training).   
 RAS mission is to maintain rehabilitation programs and services providing the right 
amount of knowledge needed to make sure these programs succeed (Rehabilitation Services 
Administration, 2012).  In order to succeed with these programs, knowledge of different diseases 
and disabilities will help an RAS plan or produce the right services for these individuals.  
Providing adequate and effective services to individuals one needs to know about his or her 
background information and his or her history with the disease.  These programs, counseling 
services, individual services and different therapies (physical, speech and occupational) should 
provide the most effective ways to help these individuals.   
A Rehabilitation Administrator can be influence by physical and emotional effects.  
These effects can be from the job or from their patients.  RAS help those with PD by ensuring 
specialized programs and funding those programs based on their needs is efficient and effective.  
RAS also direct and coordinate these programs or services to support those that has fallen victim 
of this disease as well as other diseases and disabilities.  Once the individual start receiving 
treatments, the RAS provide their input on the treatments and the quality of these treatments.  
They do this to make sure the programs are effective and progress is being made.   
It is important that the family knows the information about the disease that their family 
member has and what the programs or services are that can be provided.  Some information 
about this disease the families need to know is the symptoms, treatments, stages and ways to 
cope with PD.  The information is essential because having this knowledge of treatments and 
34 
 
 
 
diagnosing, the disease can be treated early before the symptoms get unfavorable.  Knowing the 
ways to cope with the disease will definitely have an impact of the family.  The impact would 
involve the family more than expected.  To help deal with PD the individual would need all the 
support from their family to help them get through this rough ordeal.  An additional role of an 
RAS is providing guidance to the families and a description of the services.  Services are based 
on the client’s needs; placing an individual into a program cannot be done until the needs are 
known and evaluations are done as well.   
Knowing about the stages and the medications that can help with PD is beneficial.  
Having this knowledge can help the person with the disease as well as others around them.  The 
appropriate path can help a patient deal with this disease in a timely manner.  Accurate and 
updated information can be received from the Parkinson Disease Foundation and the National 
Institute of Neurological Disorders and Stroke.   
Based on the Parkinson Disease Foundation and other foundations, research is still being 
conducted to find a cure for PD.  In today’s society, medications are being established to help 
keep symptoms under control.  An experimental drug called GM 1 ganglioside has slowed down 
PD as well as improve symptoms (Progression of Parkinson’s Disease, 2012).   
In conclusions, materials that were covered in the research are very essential.  Different 
diseases or disabilities, research has to be done in order to gain insight before any work can be 
done.  Conduct research in any form of work that is needed to provide effective knowledge and 
understanding of the work.  After doing, this research there is a better understanding of what PD 
is as well as the job description of RAS.  More knowledge and information should be conducted 
within the classes to give more insight on diseases or disabilities and how it affects an individual 
role as an RAS major.  In addition to this, practicing on developing grants, programs and 
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interacting with the clients would be a great exercise to do to give those who are studying RAS 
an opportunity to become familiar with the job description.    
Summary 
 As an RAS, the work is never done.  Their work consists of making sure that those who 
they their serving are taking care of to better themselves.  They only not do work for their 
patients they are serving but they do for the community by putting the message out in the society 
about their role and services.  RAS maintain and direct different services weather it is in the 
private sector or the public sector.  Relationships and leaderships are maintained throughout their 
careers and the services they provided.   
 As research is continuing to be done, more knowledge is being provided to those 
individuals with PD.  These individuals have many ways to seek out information, support and 
treatments to help them understand their disease.  Research is continuing until there is a cure for 
this disease but until now medications has been establish to help with symptoms that occur.  The 
Parkinson Disease Foundation website is a great place to receive updates on new and improved 
information as well as information on the disease.   
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